Quick Answer
CANNAPHARMARX, INC. reported Gross Profit of -$2.08 million for fiscal year 2025.
CANNAPHARMARX, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | -$2.08M | +29.0% |
| 2024 | -$2.93M | — |
| 2023 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$440.0K | -23.5% | +29.2% |
| June 30, 2025 | -$621.2K | -262.5% | -23.6% |
| March 31, 2025 | -$502.6K | -14.9% | -41.1% |
| September 30, 2024 | -$356.2K | — | -107.8% |
| June 30, 2024 | -$171.4K | — | +60.8% |
| March 31, 2024 | -$437.4K | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- CANNAPHARMARX, INC. showed an increase of +29.0% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: